In contrast to Let-7,miR-31 appears to be a potent stimulator of KRAS in CRC, via negative regulationof RASA1, an inhibitor of KRAS function (Kent et al., 2016; Sun et al., 2013). Here, KRAS is linked to colorectal carcinoma.